Health Economics

Financing Vaccines for Global Health Security
Jonathan T. Vu, Benjamin K. Kaplan, Shomesh Chaudhuri, Monique K. Mansoura, Andrew W. Lo

medRxiv 2020.03.20.20039966; doi: https://doi.org/10.1101/2020.03.20.20039966

Add to Selected Citations
Patient-level micro-simulation model for evaluating the future potential cost–effectiveness of pharmacy-based interventions in the control and management of diabetes-related complications in Canada
Mohsen Yaghoubi, Kerry Mansell, Hassanali Vatanparast, Wu Zeng, Mehdi Javanbakht, Marwa Farag

medRxiv 2020.03.10.20033597; doi: https://doi.org/10.1101/2020.03.10.20033597

Add to Selected Citations
Cost-effectiveness of paediatric influenza vaccination in the Netherlands
Pieter T. de Boer, Franklin C.K. Dolk, Lisa Nagy, Jan C. Wilschut, Richard Pitman, Maarten J. Postma

medRxiv 2020.03.02.20029124; doi: https://doi.org/10.1101/2020.03.02.20029124

Add to Selected Citations
Determining Personalized Community Health Needs by Feature Selection and Clustering
Matthew Agar-Johnson

medRxiv 2020.02.21.20024612; doi: https://doi.org/10.1101/2020.02.21.20024612

Add to Selected Citations
Quantitatively Evaluating the Cross-Sectoral and One Health Impact of Interventions: A Scoping Review and Application to Antibiotic Resistance
Nichola R. Naylor, Jo Lines, Jeff Waage, Barbara Wieland, Gwenan M. Knight

medRxiv 2020.01.30.20019703; doi: https://doi.org/10.1101/2020.01.30.20019703

Add to Selected Citations
The potential cost-effectiveness of controlling dengue in Indonesia using wMel Wolbachia released at scale: a modelling study
Oliver J. Brady, Dinar D. Kharisma, Nandyan N. Wilastonegoro, Kathleen M. O’Reilly, Emilie Hendricx, Leonardo S. Bastos, Laith Yakob, Donald S. Shepard

medRxiv 2020.01.11.20017186; doi: https://doi.org/10.1101/2020.01.11.20017186

Add to Selected Citations
Cost of hypertension illness and associated factors among patients attending hospitals in Southwest Shewa Zone, Oromia Regional State, Ethiopia
Addisu Bogale, Teferi Daba, Dawit Wolde Daka

medRxiv 2019.12.17.19015198; doi: https://doi.org/10.1101/2019.12.17.19015198

Add to Selected Citations
Using the Bayesian credible subgroups method to identify populations benefiting from treatment: An application to the Look AHEAD trial
Anna Coonan, John Forbes, Patrick Schnell, Joel Smith

medRxiv 2019.12.10.19014357; doi: https://doi.org/10.1101/2019.12.10.19014357

Add to Selected Citations
Impact and cost-effectiveness of nonavalent human papillomavirus vaccination in Switzerland: insights from a dynamic transmission model
Maurane Riesen, Johannes A. Bogaards, Nicola Low, Christian L. Althaus

medRxiv 19012674; doi: https://doi.org/10.1101/19012674

Add to Selected Citations
Direct medical costs of hospitalized patients with idiopathic pulmonary fibrosis in China
Xiaofen Zheng, Bingbing Xie, Yan Liu, Ming Zhu, Shu Zhang, Chengjun Ban, Jing Geng, Dingyuan Jiang, Yanhong Ren, Huaping Dai, Chen Wang

medRxiv 19010025; doi: https://doi.org/10.1101/19010025

Add to Selected Citations

Health Economics

Pages